This suggests that HK-4, by inhibiting the KHK-A protein, further reduces the activation state of the PI3K-AKT signaling pathway within tumor cells, thereby exerting its antitumor efficacy (Figure 5A). The gene discussed is AKT1; the disease is neoplasm.